| Product Code: ETC7341436 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Advance Therapy Medicinal Products Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Advance Therapy Medicinal Products Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Advance Therapy Medicinal Products Market - Industry Life Cycle |
3.4 Greece Advance Therapy Medicinal Products Market - Porter's Five Forces |
3.5 Greece Advance Therapy Medicinal Products Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 Greece Advance Therapy Medicinal Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of advanced therapy medicinal products (ATMPs) in Greece due to their effectiveness in treating complex diseases. |
4.2.2 Growing investments in research and development of ATMPs by pharmaceutical companies and biotech firms. |
4.2.3 Favorable regulatory environment and government support for the development and commercialization of ATMPs in Greece. |
4.3 Market Restraints |
4.3.1 High cost associated with ATMPs leading to affordability issues for patients and healthcare systems. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about the benefits and availability of ATMPs in Greece. |
5 Greece Advance Therapy Medicinal Products Market Trends |
6 Greece Advance Therapy Medicinal Products Market, By Types |
6.1 Greece Advance Therapy Medicinal Products Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Greece Advance Therapy Medicinal Products Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Greece Advance Therapy Medicinal Products Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Greece Advance Therapy Medicinal Products Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.5 Greece Advance Therapy Medicinal Products Market Revenues & Volume, By CAR-T Therapy, 2021- 2031F |
6.1.6 Greece Advance Therapy Medicinal Products Market Revenues & Volume, By Tissue Engineered Product, 2021- 2031F |
7 Greece Advance Therapy Medicinal Products Market Import-Export Trade Statistics |
7.1 Greece Advance Therapy Medicinal Products Market Export to Major Countries |
7.2 Greece Advance Therapy Medicinal Products Market Imports from Major Countries |
8 Greece Advance Therapy Medicinal Products Market Key Performance Indicators |
8.1 Number of clinical trials conducted for ATMPs in Greece. |
8.2 Percentage of healthcare professionals trained in the use of ATMPs. |
8.3 Patient satisfaction rates with ATMP treatments. |
8.4 Rate of reimbursement approval for ATMPs by healthcare payers in Greece. |
8.5 Number of partnerships between academic institutions, industry players, and government bodies to promote the development of ATMPs in Greece. |
9 Greece Advance Therapy Medicinal Products Market - Opportunity Assessment |
9.1 Greece Advance Therapy Medicinal Products Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10 Greece Advance Therapy Medicinal Products Market - Competitive Landscape |
10.1 Greece Advance Therapy Medicinal Products Market Revenue Share, By Companies, 2024 |
10.2 Greece Advance Therapy Medicinal Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here